**Author details**

Huseyin Istanbullu1 \* and Gulsah Bayraktar2

1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir, Turkey

2 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey

\*Address all correspondence to: huseyin.istanbullu@ikc.edu.tr

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Toward New Antileishmanial Compounds: Molecular Targets for Leishmaniasis Treatment DOI: http://dx.doi.org/10.5772/intechopen.101132*
